Literature DB >> 15915074

B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.

Asife Sahinarslan1, Atiye Cengel, Kaan Okyay, Huseyin Ugur Yazici, Sehri Elbey, Mustafa Cemri, Murat Ozdemir, Timur Timurkaynak.   

Abstract

OBJECTIVE: Although it is well established that plasma B-type natriuretic peptide (BNP) levels are higher in patients with acute coronary syndromes, the relationship between plasma BNP level and stable coronary artery disease is not clear. The aim of this study was to examine the relationship between plasma BNP levels and the extent of obstructive lesions on coronary angiography in stable coronary artery patients.
METHODS: Plasma BNP concentrations were measured in 62 patients with a diagnosis of stable angina pectoris who had a left ventricular ejection fraction (LVEF) >or=45% on echocardiographic evaluation. Coronary angiography was performed for all patients, who were than divided into two groups according to the results of the angiography. Group I consisted of the patients who had a lesion leading to an obstruction of the lumen in any coronary artery by less than 50% or those who had normal coronary arteries. All other patients constituted group II.
RESULTS: In group I (n=26), the mean plasma BNP level was 64.8+/-29.5 pg/ml. In group II (n=36), it was 99.7+/-55.4 pg/ml. BNP was significantly higher in group II (P=0.007) than group I. The BNP concentration of the patients with one-vessel disease (n=12), two-vessel disease (n=16), and three-vessel disease (n=8) were 77.9+/-34.9 pg/ml, 109.3+/-67.9 pg/ml, 113.3+/-48.1 pg/ml consecutively. In this respect, the plasma BNP was significantly higher in the groups with more extended vessel disease (P=0.02). When we compared the patients according to involvement of left anterior descending artery (LAD), BNP levels were significantly higher in this group, (116.1+/-55.8 pg/ml versus 64.1+/-30.2 pg/ml; P=0.001).
CONCLUSION: Plasma levels of BNP were higher in patients who have stable coronary artery disease with preserved left ventricular systolic function. The level of increase in plasma BNP concentration was positively correlated with the extent of lesion and LAD involvement on coronary angiography.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15915074     DOI: 10.1097/00019501-200506000-00003

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  5 in total

1.  Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.

Authors:  Aylin Yildirir; Sadik Acikel; Cagatay Ertan; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  Tex Heart Inst J       Date:  2007

2.  NT-proBNP is associated with SYNTAX score and aortic distensibility in patients with stable CAD.

Authors:  D Y Sahin; M Gür; Z Elbasan; N Y Koyunsever; C Türkoğlu; S Akyol; A Yıldırım; G Gözübüyük; B Ozaltun; M Caylı
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

3.  Additive Value of B-Type Natriuretic Peptide on Rest Tl-Dipyridamole Stress Tc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function.

Authors:  Jung-Ju Sir; Young-Seok Cho; Woo-Young Chung; Bon-Kwon Koo; In-Ho Chae; Dong-Ju Choi; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  Cardiol Res Pract       Date:  2010-04-12       Impact factor: 1.866

4.  Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements.

Authors:  Venous Shahabi; Mansour Moazenzadeh; Behzad Sarvar Azimzadeh; Hamidreza Nasri; Reza Malekpoor Afshar; Armita Shahesmaili; Hamidreza Rashidinejad
Journal:  J Res Med Sci       Date:  2011-02       Impact factor: 1.852

5.  Does Serum N-Terminal pro-Brain Natriuretic Peptide Level Predict the Severity of Angiographic Lesions in Patients with Acute Coronary Syndrome?

Authors:  Afsaneh Rajabiani; Abbas Mohaghgheghi; Daryoush Kamal-Hedayat; Sara Sheikhbahaei; Alireza Abdollahi; Sepideh Rezaei Adl; Hossein Sateh
Journal:  J Tehran Heart Cent       Date:  2013-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.